The need for safe remote monitoring during the COVID-19 epidemic
As the need for remote health monitoring intensifies during the COVID-19 epidemic, Sensyne Health are developing and deploying products that enable patient groups to record their health information and be safely managed at home, clinicians to deliver continued contact and care, and healthcare organisations such as the NHS to reduce pressure on their resources.
Data generated from these products contributes to medical research aimed at predicting, diagnosing, treating and preventing a variety of conditions including COVID-19 infection.
Clinically led. Evidence based. AI powered.
A new approach that benefits life sciences, NHS and patients
Sensyne Health is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts.
These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance.
Sensyne Health was an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.
